Used in biomedical research to detect and quantify intestinal fatty acid binding protein (iFABP) in biological samples such as serum, plasma, or tissue homogenates. This ELISA kit is particularly valuable in studies related to intestinal injury, as iFABP is released into the bloodstream upon damage to intestinal epithelial cells. It is widely applied in research on conditions like necrotizing enterocolitis, inflammatory bowel disease, ischemia-reperfusion injury, and gut barrier dysfunction. The assay enables early detection of enterocyte damage, helping researchers assess disease severity, monitor treatment efficacy, and investigate gut health in experimental models. Due to its sensitivity and specificity, this kit supports high-throughput analysis in both clinical and preclinical settings.